Position in EOLS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$588,402
-$327,945 QoQ
Shares Held
143,164
+3.9% QoQ
Ownership
0.217%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $1,371,862,681 across 46 Drug Manufacturers - Specialty & Generic names. EOLS ranks #38 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,899,720 | $460,985,889 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
329,148 | $195,178,172 | |
| 3 | VTRS |
Viatris Inc
|
14,128,917 | $190,881,662 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
702,492 | $92,546,288 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,809,888 | $91,170,611 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,794,432 | $54,048,287 | |
| 7 | ALKS |
Alkermes plc.
|
1,036,460 | $36,649,221 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
463,751 | $35,175,507 |
All Filings in EOLS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $588,402 | 143,164 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $916,347 | 137,797 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $876,913 | 142,820 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,298,654 | 141,005 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,632,529 | 135,705 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,508,051 | 136,599 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $2,212,692 | 136,586 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,964,857 | 181,093 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $2,034,662 | 145,333 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,706,732 | 162,083 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,499,140 | 164,020 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,061,570 | 146,021 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,045,214 | 123,548 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $918,194 | 122,263 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $984,337 | 122,278 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,873,700 | 161,526 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,200,830 | 107,026 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $687,155 | 105,554 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $790,246 | 103,707 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $1,101,598 | 87,083 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $988,563 | 76,102 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $326,643 | 83,541 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $448,511 | 84,625 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $340,061 | 81,943 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||